Copyright 2016 American Medical Association. All Rights Reserved.
Deficiency of the interleukin (IL)-36 receptor antagonist (DITRA) is a recently described autosomal recessive auto-inflammatory syndrome caused by mutations in the IL36RN gene, characterized clinically by recurrent episodes of generalized skin pustulation, fever, systemic inflammation and leukocytosis.1,2 A uniformly effective treatment for DITRA has not been identified.
Cordoro KM, Ucmak D, Hitraya-Low M, Rosenblum MD, Liao W. Response to Interleukin (IL)-17 Inhibition in an Adolescent With Severe Manifestations of IL-36 Receptor Antagonist Deficiency (DITRA). JAMA Dermatol. 2017;153(1):106–108. doi:10.1001/jamadermatol.2016.3490
Customize your JAMA Network experience by selecting one or more topics from the list below.